About the VHIR
Here at the Vall d'Hebron Research Institute (VHIR) we promote biomedical research, innovation and teaching. Over 1,800 people are seeking to understand diseases today so the treatment can be improved tomorrow.
Research
We are working to understand diseases, to find out how they operate and to create better treatments for patients. Get to know about our groups and their lines of research.
People
People are the centre of the Vall d'Hebron Research Institute (VHIR). This is why we are bound by the principles of freedom of research, gender equality and professional attitudes that HRS4R promotes.
Clinical trials
Our work is not just basic or translational; we are leaders in clinical research. Enter and find about the clinical trials we are conducting and why we are a world reference in this field.
Progress
Our aim is to make the research carried out at the Vall d’Hebron Research Institute (VHIR) a driving force for transformation. How? By identifying new channels and solutions for the promotion of people's health and well-being.
Core facilities
We offer specialist support for researchers, internal and external alike, ranging from specific services to preparing complete projects. All this, from a perspective of quality and speed of response.
News
We offer you a gateway for staying up to date on everything going on at the Vall d’Hebron Research Institute (VHIR), from the latest news to future solidarity activities and initiatives that we are organising.
The main characteristic of our group is its multidisciplinary nature, as it is comprised of neuroradiologists, technologists, and a physicist, engineer, and biochemist.
The main objectives of our projects are to gain knowledge about the pathophysiologic mechanisms implicated in several neurological diseases and to evaluate new biomarkers and therapies through the use of qualitative and quantitative magnetic resonance (MR) and computed tomography (CT) techniques, and by applying artificial intelligence tools to create prognostic models. Our focus is on the study of diseases such as multiple sclerosis, epilepsy, neuro-oncology, and stroke.
In addition, because of the experience we have acquired along the years in performing MR studies, we act as a platform for designing MR-based projects, processing images, and conducting quantitative data analysis.
The objective of the line is to evaluate the added value of the information provided by quantitative MR techniques, mainly T1 and T2 relaxometry, as well as chemical exchange saturation transfer imaging (CEST) to the study of neurological and neuro-oncological diseases.
IP: Fco. Javier Aymerich Martínez, Alex Rovira Cañellas, Cristina Auger Acosta
The goal would be to assess the impact of diabetes on brain morphology, integrity and function through the advanced analysis of magnetic resonance images.
IP: Deborah Pareto Onghena, Alex Rovira Cañellas
The goal would be to assess the feasibility and the impact of new magnetic resonance sequences and image analysis tools in the characterization of patients with migraine.
The aim of the line is to evaluate the usefulness of MRI in the study of pituitary tumors, diagnosis and follow-up. The study focuses on the radiological characteristics of tumors that can predict their prognosis. Advances in neuroimaging and behavior of pituitary tumors specifically of macroadenomas are also evaluated, focusing on the radiological characteristics and their potential use with genetic and molecular markers, radiomic ACROFAST project which is a multicenter project.
IP: Silvana Isabel Sarria Estrada
IP: Deborah Pareto Onghena Collaborators: Ingrid Galán Cartaña, Juan Fco. Corral Gamez, Herena Eixarch Ahufinger, M Jesus Arevalo Navines, Andrea De Barros Figueredo, Neus Mongay Ochoa, Giorgio Colangelo Funding agency: Instituto de Salud Carlos III Funding: 87120 Reference: PI22/01709 Duration: 01/01/2023 - 31/12/2025
IP: Jaume Sastre Garriga Collaborators: Cristina Auger Acosta, Carme Santoyo Medina, Manel Alberich Jordà, M Jesus Arevalo Navines, Xavier Montalban Gairín, Lucía Gutiérrez Ruiz, Neus Mongay Ochoa Funding agency: Instituto de Salud Carlos III Funding: 157300 Reference: PI22/00750 Duration: 01/01/2023 - 31/12/2025
IP: Angela Vidal Jordana Collaborators: Dulce María Moncho Rodríguez, Alex Rovira Cañellas, Manel Alberich Jordà, Neus Mongay Ochoa, Joaquin Castillo Justribo, Sergio Cabello Funding agency: Instituto de Salud Carlos III Funding: 48400 Reference: PI22/01589 Duration: 01/01/2023 - 31/12/2025
IP: Ramón Vilallonga Puy Collaborators: Mercedes Pérez Lafuente, Nuria Roson Gradaille, Laura Puente Ramo, Carla Gonzalez Junyent, Marta Comas Martínez, Alba Rojano Toimil, Arturo Cirera De Tudela, Jesus Manuel Rivera Esteban Funding agency: Instituto de Salud Carlos III Funding: 171820 Reference: PI22/00880 Duration: 01/01/2023 - 31/12/2025
PMID: 37951697 Journal: NEUROIMAGING CLINICS OF NORTH AMERICA Year: 2024 Reference: Neuroimaging Clin N Am. 2024 Feb;34(1):113-128. doi: 10.1016/j.nic.2023.07.003. Epub 2023 Oct 10. Impact factor: Publication type: Paper in international publication Authors: Puac-Polanco, Paulo; Rivas Rodriguez, Francisco; Rovira, Alex; Shah, Lubdha M; Torres, Carlos; Wiggins, Richard H et al. DOI: 10.1016/j.nic.2023.07.003
PMID: 36940621 Journal: NeuroImage-Clinical Year: 2023 Reference: Neuroimage Clin. 2023;38:103376. doi: 10.1016/j.nicl.2023.103376. Epub 2023 Mar 15. Impact factor: Publication type: Paper in international publication Authors: Alberich, Manel; Arrambide, Georgina; Auger, Cristina; Carbonell-Mirabent, Pere; Castillo, Joaquin; Cobo-Calvo, Alvaro; Coll, Llucia; Coll, Llucia; Comabella, Manuel; Galan, Ingrid et al. DOI: 10.1016/j.nicl.2023.103376
PMID: 36990717 Journal: NEUROLOGY Year: 2023 Reference: Neurology. 2023 Aug 1;101(5):e570-e575. doi: 10.1212/WNL.0000000000207246. Epub 2023 Mar 29. Impact factor: Publication type: Letter or abstract Authors: Auger, Cristina; Baucells, Andres; Gonzalez, Victoria; Llaurado, Arnau; Rodrigo-Gisbert, Marc et al. DOI: 10.1212/WNL.0000000000207246
PMID: 37046396 Journal: REVISTA DE NEUROLOGIA Year: 2023 Reference: Rev Neurol. 2023 Apr 16;76(8):273-275. doi: 10.33588/rn.7608.2022328. Impact factor: Publication type: Letter or abstract Authors: Anton-Jimenez, A; Martinez-Saez, E; Rovira, A; Sarria-Estrada, S; Tortajada-Bustelo, J C et al. DOI: 10.33588/rn.7608.2022328
PMID: 37061243 Journal: Revista espanola de patologia Year: 2023 Reference: Rev Esp Patol. 2023 Apr-Jun;56(2):140-143. doi: 10.1016/j.patol.2022.03.002. Epub 2022 Jun 15. Impact factor: Publication type: Letter or abstract Authors: Arcediano, Miguel Angel; Dinares, Carme; Dinares, Carme; Naranjo, Lourdes; Ramon Y Cajal, Santiago; Ramon Y Cajal, Santiago; Romagosa, Cleofe; Romagosa, Cleofe; Salazar-Huayna, Lourdes; Siurana, Sahyly et al. DOI: 10.1016/j.patol.2022.03.002
PMID: 33870790 Journal: Multiple Sclerosis Journal Year: 2022 Reference: Mult Scler. 2022 Jan;28(1):71-81. doi: 10.1177/13524585211010082. Epub 2021 Apr 19. Impact factor: 6.312 Publication type: Paper in international publication Authors: Pinteac, Rucsanda; Granziera, Cristina; Sastre-Garriga, Jaume; Benkert, Pascal; Auger, Cristina; Kuhle, Jens; Montalban, Xavier; Rovira, Alex; Fissolo, Nicolas; Pareto, Deborah et al. DOI: 10.1177/13524585211010082
PMID: 34716250 Journal: NEUROLOGY Year: 2022 Reference: Neurology. 2022 Jan 4;98(1):e1-e14. doi: 10.1212/WNL.0000000000013016. Epub 2021 Oct 29. Impact factor: 9.91 Publication type: Paper in international publication Authors: Filippi, Massimo; Preziosa, Paolo; Meani, Alessandro; Costa, Gloria Dalla; Mesaros, Sarlota; Drulovic, Jelena; Ivanovic, Jovana; Rovira, Alex; Tintore, Mar; Montalban, Xavier et al. DOI: 10.1212/WNL.0000000000013016
PMID: 34596743 Journal: JOURNAL OF NEUROLOGY Year: 2022 Reference: J Neurol. 2022 Jan;269(1):452-459. doi: 10.1007/s00415-021-10823-z. Epub 2021 Oct 1. Impact factor: 4.849 Publication type: Paper in international publication Authors: Tur, Carmen; Auger, Cristina; Sastre-Garriga, Jaume; Montalban, Xavier; Cobo, Alvaro; Nos, Carlos; Arrambide, Georgina; Castillo, Joaquim; Rio, Jordi; Gasperini, Claudio et al. DOI: 10.1007/s00415-021-10823-z
PMID: 34988947 Journal: ACTA NEUROLOGICA BELGICA Year: 2022 Reference: Acta Neurol Belg. 2022 Jun;122(3):823-825. doi: 10.1007/s13760-021-01864-2. Epub 2022 Jan 6. Impact factor: 2.396 Publication type: Letter or abstract Authors: Lallana, Sofia; Sanchez-Tejerina, Daniel; Auger, Cristina; Callejo, Ana; Rio, Jordi; Cobo-Calvo, Alvaro et al. DOI: 10.1007/s13760-021-01864-2
PMID: 34859704 Journal: Multiple Sclerosis Journal Year: 2021 Reference: Mult Scler. 2021 Dec 3:13524585211061339. doi: 10.1177/13524585211061339. Impact factor: 6.312 Publication type: Paper in international publication Authors: Rovira, Alex, Corral, Juan Francisco, Auger, Cristina, Valverde, Sergi, Vidal-Jordana, Angela, Ng Wong, Yiken Karelys, Tintore, Mar, Pareto, Deborah, Aymerich, Francesc Xavier, Montalban, Xavier et al. DOI: 10.1177/13524585211061339
PMID: 33841903 Journal: BJR case reports Year: 2021 Reference: BJR Case Rep. 2021 Jan 5;7(2):20200133. doi: 10.1259/bjrcr.20200133. eCollection 2021 Apr 1. Impact factor: 0 Publication type: Letter or abstract Authors: Pessini Ferreira, Lucas Maria, Auger, Cristina, Kortazar Zubizarreta, Izaro, Gonzalez Chinchon, Gonzalo, Herrera, Isabel, Pla, Albert, de Barros, Andrea, Tortajada, Carlos, Rovira, Alex et al. DOI: 10.1259/bjrcr.20200133
PMID: 32439639 Journal: AMERICAN JOURNAL OF NEURORADIOLOGY Year: 2020 Reference: AJNR Am J Neuroradiol. 2020 Jun;41(6):1001-1008. doi: 10.3174/ajnr.A6547. Epub 2020 May 21. Impact factor: 3.381 Publication type: Paper in international publication Authors: Tintore, M, Sastre-Garriga, J, Auger, C, Montalban, X, Evangelou, N, Rovira, A, Cappelle, S, Crescenzo, F, Alberich, M, Arrambide, G et al. DOI: 10.3174/ajnr.A6547
PMID: 32139431 Journal: AMERICAN JOURNAL OF NEURORADIOLOGY Year: 2020 Reference: AJNR Am J Neuroradiol. 2020 Mar;41(3):461-463. doi: 10.3174/ajnr.A6481. Epub 2020 Mar 5. Impact factor: 3.381 Publication type: Paper in international publication Authors: Pareto, D, Garcia-Vidal, A, Alberich, M, Auger, C, Montalban, X, Tintore, M, Sastre-Garriga, J, Rovira, A et al. DOI: 10.3174/ajnr.A6481
PhD student: Silvana Isabel Sarria Estrada Director/s: Jordi Giralt López de Sagred University: Universidad Autònoma de Barcelona Year: 2021
Els doctors Xavier Montalban, Àlex Rovira i Mar Tintoré han estat reconeguts en la categoria de Neurociències i Comportament, i el doctor Jordi Rello en la categoria Interdisciplinària.
The program, promoted by Biocat in collaboration with CIMIT (Boston), is aimed at entrepreneurs in the process of bringing their technology to market in the next few years.
